エピソード

  • Allogeneic Stem Cell Transplant for MDS: Advanced Considerations (Part II) [MDS Patient & Family Report]

    Allogeneic Stem Cell Transplant for MDS: Advanced Considerations (Part II) [MDS Patient & Family Report]
    2026/01/06
    In this follow-up episode, Dr. Nikolaos Papadantonakis continues the conversation with Dr. Colin Vale from Winship Cancer Institute of Emory University and Dr. Nancy Luna Torres from Moffitt Cancer Center, diving deeper into advanced transplant topics. This episode is ideal for patients and families who want to understand the nuances of transplant care and post-transplant management.
    続きを読む 一部表示
    31 分
  • Allogeneic Stem Cell Transplant for MDS: Understanding the Basics (Part I) [MDS Patient & Family Report]

    Allogeneic Stem Cell Transplant for MDS: Understanding the Basics (Part I) [MDS Patient & Family Report]
    2026/01/06
    Join host Dr. Nikolaos Papadantonakis as he welcomes Dr. Colin Vale from Winship Cancer Institute of Emory University and Dr. Nancy Luna Torres from Moffitt Cancer Center to discuss the fundamentals of allogeneic hematopoietic stem cell transplantation for MDS patients. Our experts break down complex medical concepts into easy-to-understand language, helping patients make informed decisions about this important treatment option.
    続きを読む 一部表示
    31 分
  • EHA 2025 updates [MDS Patient & Family Report]

    EHA 2025 updates [MDS Patient & Family Report]
    2025/09/26
    This episode features Dr. Nikolaos Papadantonakis from the Winship Cancer Institute of Emory University and Dr. Amer Zeidan from the Yale School of Medicine, discussing research on Myelodysplastic Syndromes (MDS) presented at the 2025 European Hematology Association (EHA) Congress in Milan.
    続きを読む 一部表示
    23 分
  • ASH 2024: MDS in Focus [MDS Patient & Family Report]

    ASH 2024: MDS in Focus [MDS Patient & Family Report]
    2025/02/25
    Join Dr. Madanat (UT Southwestern, Texas), Dr. Stahl (Harvard Medical School, Massachusetts), and Dr. Papadantonakis (Emory University, Georgia) as they break down key Myelodysplastic Syndromes (MDS) abstracts from the 2024 American Society of Hematology (ASH) meeting.

    Tune in to gain valuable insights and stay informed about the evolving landscape of MDS management.
    続きを読む 一部表示
    34 分
  • MDS Highlights of the 2024 European Hematology Association Congress [MDS Patient & Family Report]

    MDS Highlights of the 2024 European Hematology Association Congress [MDS Patient & Family Report]
    2024/10/28
    Dr. Rena Buckstein and Dr. Moshe Mittelman join Dr. Nikolaos Papadantonakis to discuss key MDS abstracts presented in the 2024 European Hematology Association Congress. Topics covered include anemia and the role of ivosidenib in higher risk MDS.
    続きを読む 一部表示
    36 分
  • Introduction to cytogenetics and mutational testing in MDS [MDS Patient & Family Report]

    Introduction to cytogenetics and mutational testing in MDS [MDS Patient & Family Report]
    2024/07/29
    Dr. Nikolaos Papadantonakis discusses cytogenetics and mutational testing in MDS with Dr. Hetty Carraway and Dr. Moshe Mittelman and how they utilize this information in the clinical setting.
    続きを読む 一部表示
    30 分
  • Overview of MDS treatments [MDS Patient & Family Report]

    Overview of MDS treatments [MDS Patient & Family Report]
    2024/04/30
    In this episode, Dr. Papadantonakis from Winship Cancer Institute of Emory University, Atlanta, US, and Dr. Mittelman, chairman of the MDS Foundation scientific board, discuss the range of treatment options for patients with MDS.
    続きを読む 一部表示
    26 分
  • New drugs for anemia of lower-risk MDS [MDS Patient & Family Report]

    New drugs for anemia of lower-risk MDS [MDS Patient & Family Report]
    2024/03/27
    MDS experts Drs Nikolaos Papadantonakis of Emory, Atlanta, US, and Moshe Mittelman, Tel-Aviv, Israel, discuss new trials presented in the last meeting of the American Society of Hematology (ASH) 2023. They focus on luspatercept, imetelstat and roxodustat.
    続きを読む 一部表示
    27 分